Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N Rose

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
JAMA|January 24, 1998
AIDS drug regimens that are worth their costsD N Rose
Archives of Internal Medicine|March 25, 1996
Benefits of isoniazid preventive therapyD N Rose
Archives of Internal Medicine|May 29, 2000
Benefits of screening for latent Mycobacterium tuberculosis infectionD N Rose
Occupational Medicine (Philadelphia, Pa.)|October 1, 1994
The relationship between TB and HIV infectionsD N Rose
Annals of Internal Medicine|December 5, 1998
Short-course prophylaxis against tuberculosis in HIV-infected persons. A decision and cost-effectiveness analysisD N Rose
The Mount Sinai Journal of Medicine, New York|November 1, 1992
The epidemiology of HIV infection and AIDS in east and central Harlem, NYD N Rose
Annals of Internal Medicine|August 1, 1989
Life expectancies: population or person?A L Silver, D N Rose
AIDS (London, England)|February 1, 1993
The safety of Bacille Calmette-Guérin vaccination in HIV infection and AIDSA C Weltman, D N Rose
Archives of Internal Medicine|October 10, 1994
Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospitalA C Weltman, D N Rose
AIDS (London, England)|June 1, 1997
Cost-effectiveness of cytomegalovirus (CMV) disease prevention in patients with AIDS: oral ganciclovir and CMV polymerase chain reaction testingD N Rose, H S Sacks
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
JAMA|January 24, 1998
AIDS drug regimens that are worth their costsD N Rose
Archives of Internal Medicine|March 25, 1996
Benefits of isoniazid preventive therapyD N Rose
Archives of Internal Medicine|May 29, 2000
Benefits of screening for latent Mycobacterium tuberculosis infectionD N Rose
Occupational Medicine (Philadelphia, Pa.)|October 1, 1994
The relationship between TB and HIV infectionsD N Rose
Annals of Internal Medicine|December 5, 1998
Short-course prophylaxis against tuberculosis in HIV-infected persons. A decision and cost-effectiveness analysisD N Rose
The Mount Sinai Journal of Medicine, New York|November 1, 1992
The epidemiology of HIV infection and AIDS in east and central Harlem, NYD N Rose
Annals of Internal Medicine|August 1, 1989
Life expectancies: population or person?A L Silver, D N Rose
AIDS (London, England)|February 1, 1993
The safety of Bacille Calmette-Guérin vaccination in HIV infection and AIDSA C Weltman, D N Rose
Archives of Internal Medicine|October 10, 1994
Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospitalA C Weltman, D N Rose
AIDS (London, England)|June 1, 1997
Cost-effectiveness of cytomegalovirus (CMV) disease prevention in patients with AIDS: oral ganciclovir and CMV polymerase chain reaction testingD N Rose, H S Sacks
Pageof 5